Patents by Inventor Cynthia Ann Parrish

Cynthia Ann Parrish has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fatty acid synthase inhibitors
    Patent number: 9725437
    Abstract: This invention relates to triazolones and triazolones for the modulation, notably the inhibition of the activity or function of fatty acid synthase (FAS). Suitably, the present invention relates to the use of triazolones in the treatment of cancer.
    Type: Grant
    Filed: September 8, 2016
    Date of Patent: August 8, 2017
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
    Inventor: Cynthia Ann Parrish
  • FATTY ACID SYNTHASE INHIBITORS
    Publication number: 20160376257
    Abstract: This invention relates to triazolones and triazolones for the modulation, notably the inhibition of the activity or function of fatty acid synthase (FAS). Suitably, the present invention relates to the use of triazolones in the treatment of cancer.
    Type: Application
    Filed: September 8, 2016
    Publication date: December 29, 2016
    Inventor: Cynthia Ann PARRISH
  • Triazolones as fatty acid synthase inhibitors
    Patent number: 9340529
    Abstract: This invention relates to the use of triazolone derivatives for the modulation, notably the inhibition of the activity or function of fatty acid synthase (FAS). Suitably, the present invention relates to the use of triazolones in the treatment of cancer.
    Type: Grant
    Filed: November 4, 2013
    Date of Patent: May 17, 2016
    Assignee: GlaxoSmithKline LLC
    Inventors: Nicholas David Adams, Christopher Joseph Aquino, Amita M. Chaudhari, Jonathan Michael Ghergurovich, Terence John Kiesow, Cynthia Ann Parrish, Alexander Joseph Reif, Kenneth Wiggall
  • FATTY ACID SYNTHASE INHIBITORS
    Publication number: 20150329524
    Abstract: This invention relates to triazolones and triazolones for the modulation, notably the inhibition of the activity or function of fatty acid synthase (FAS). Suitably, the present invention relates to the use of triazolones in the treatment of cancer.
    Type: Application
    Filed: January 10, 2014
    Publication date: November 19, 2015
    Inventor: Cynthia Ann PARRISH
  • Fatty acid synthase inhibitors
    Patent number: 9084794
    Abstract: This invention relates to spirocyclic piperidines according to Formula (I) and the use of spirocyclic piperidines for the modulation, notably the inhibition of the activity or function of fatty acid synthase (FAS). Suitably, the present invention relates to the use of spirocyclic piperidines in the treatment of cancer.
    Type: Grant
    Filed: August 16, 2012
    Date of Patent: July 21, 2015
    Assignee: GlaxoSmithKline Intellectual Property (No. 2) Limited
    Inventors: Jonathan Michael Ghergurovich, Michael Lee Moore, Cynthia Ann Parrish, Lance Howard Ridgers, Hongyi Lu
  • FATTY ACID SYNTHASE INHIBITORS
    Publication number: 20140194415
    Abstract: This invention relates to spirocyclic piperidines according to Formula (I) and the use of spirocyclic piperidines for the modulation, notably the inhibition of the activity or function of fatty acid synthase (FAS). Suitably, the present invention relates to the use of spirocyclic piperidines in the treatment of cancer.
    Type: Application
    Filed: August 16, 2012
    Publication date: July 10, 2014
    Applicant: GlaxoSmithKline Intellectual Property (No2) Limite
    Inventors: Jonathan Michael Ghergurovich, Michael Lee Moore, Cynthia Ann Parrish, Lance Howard Ridgers, Hongyi Lu
  • TRIAZOLONES AS FATTY ACID SYNTHASE INHIBITORS
    Publication number: 20140100213
    Abstract: This invention relates to the use of triazolone derivatives for the modulation, notably the inhibition of the activity or function of fatty acid synthase (FAS). Suitably, the present invention relates to the use of triazolones in the treatment of cancer.
    Type: Application
    Filed: November 4, 2013
    Publication date: April 10, 2014
    Applicant: GlaxoSmithKline LLC
    Inventors: Nicholas David Adams, Christopher Joseph Aquino, Amita M. Chaudhari, Jonathan Michael Chergurovich, Terence John Kiesow, Cynthia Ann Parrish, Alexander Joseph Reif, Kenneth Wiggall
  • FATTY ACID SYNTHASE INHIBITORS
    Publication number: 20130237535
    Abstract: This invention relates to the use of spirocyclic piperidine derivatives for the modulation, notably the inhibition of the activity or function of fatty acid synthase (FAS). Suitably, the present invention relates to the use of spirocyclic piperidines in the treatment of cancer.
    Type: Application
    Filed: November 7, 2011
    Publication date: September 12, 2013
    Inventors: Nicholas D. Adams, Amita M. Chaudhari, Terence John Kiesow, Cynthia Ann Parrish, Alexander Joseph Reif, Lance Howard Ridgers, Stanley J. Schmidt, Kenneth Wiggall